Tagactac, Placidad D.
HRN: 24-18-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/07/2023
12/13/2023
IVT
1.5g
Q6
Herpes Zoster Ophthalmicus; Soft Tissue Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes